Latest

What you eat could alter your unborn children and grandchildren’s genes and health outcomes
A reformed points test to drive Australia’s long-term prosperity
Australia’s healthcare system among the most productive in the world
UN Human Rights Chief deplores harrowing killings of children and women in Rafah
Police Charge Woman With Drug Supply At Muswellbrook
Flat faces and difficulty breathing: how pet trends have harmed animal health – and what we can we do about it
Tag On To Our Plan For Tackling Graffiti
In Cameroon, FAO supports World Bank-funded project targeting nutrition, early warning systems, resilience and capacity-building for small-scale farmers
New insights into the molecular mechanisms behind the action of secretagogin
Flat faces and difficulty breathing: how pet trends has harmed animal health – and what we can we do about it

RSV NUYINA ARRIVAL EVENTS CANCELLED DUE TO Covid 15 October 2021

Environment
15 Oct 2021 2:18 pm AEST Date Time
Share

Australian Antarctic Division

Due to the recently announced Tasmanian COVID-19 lockdown, plans to welcome Australia’s new Antarctic icebreaker, RSV Nuyina have changed.

A red ship on the horizon heading away from camera — RSV Nuyina leaving the Canary Islands Photo: Pete Harmsen/AAD

In line with advice from Tasmanian Public Health, Tasmanians will now no longer be permitted to greet the new ship from the waterfront or out on the River Derwent.

Planned activities at the Tasmanian Museum and Art Gallery and Waterside Pavilion will close for the duration of the lockdown.

The Australian Antarctic Division will share arrival vision and stills on the Nuyina website as the day unfolds.

/Public Release. View in full here.

West Antarctica’s ice sheet was smaller thousands of years ago – here’s why this matters today

Oz Lotto results: Winning numbers in draw 1575

Ashurst advises Volac and its owners on sale of Volac Whey Nutrition to Arla Foods

Delirium ID toolkit boosts carer knowledge to prevent, manage the condition

City of Newcastle moves forward with multimillion-dollar upgrade plans for Georgetown

WHO Global Malaria Programme launches new operational strategy

Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia

UN leaders warn of harmful consequences: UK-Rwanda asylum law